| Date | Form | Description | Docs | XBRL | Pages |
| 06/14/01 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
22 | |
| 06/13/01 | 8-K | Current report filing |
|
5 | |
| 03/19/01 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 02/01/01 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/29/01 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/09/01 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
6 | |
| 09/14/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 06/13/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 06/12/00 | DEF 14A | Definitive proxy statements |
|
24 | |
| 03/15/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 |
Latest News & Events
Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones
Read More...Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Read More...Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...